Search contract descriptions, companies and agencies.
CENTRALIZED MOLECULAR ASSESSMENT OF SARS AND INFLUENZA VIRUS INFECTION FOR MULTI-SITE PROSPECTIVE COHORTS
Total Committed
$20.6M
Product or Service Description
Biomedical R&D
Total Potential Value
$22.6M
Contracting Agency
Effective Date
June 15, 2020
Funding Department
CDC OFFICE OF ACQUISITION SERVICES
Type
Cost no fee
Solicitation Procedure
Only one source
Extent Competed
Not competed
Reason
Urgency (Far 6.302 2)
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| MARSHFIELD CLINIC | CENTRALIZED MOLECULAR ASSESSMENT OF SARS AND INFLUENZA VIRUS INFECTION FOR MULTI-SITE PROSPECTIVE COHORTS | June 29, 2020 | $20,553,604 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.